Ottobock, Duderstadt, Germany, announced that its healthcare segment showed increased sales of 9.9 percent (7 percent adjusted for currency effects) in 2015. The company credited the sales growth to products such as the Kenevo transfemoral prosthesis, further developments like the fourth generation of the C-Leg, and the expansion of the global network in patient care and fittings.
In the United States, sales increased 29.3 percent to 172 million euros (about US $198.3 million), or 8 percent growth when adjusted for currency effects. Ottobock credited the increase to its mechatronic innovations, the breadth of the product portfolio, and its mechanical solutions. Sales in Germany, Austria, and Switzerland were 122 million euros (about US $140.6 million), or 4.5 percent growth, while sales in Western Europe as a whole grew by 5.2 percent to 443 million euros (about US $510.6 million).
Ottobock said its Clinical Services Network will occupy a key position in future growth; the company currently has more than 130 patient clinics of its own.
